Filtered By:
Drug: Medroxyprogesterone
This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 487 results found since Jan 2013.
Menopausal Hormone Therapy and Breast Cancer
Cancer J. 2022 May-Jun 01;28(3):169-175. doi: 10.1097/PPO.0000000000000601.ABSTRACTAssociations of estrogen-alone and estrogen plus progestin with breast cancer incidence and related mortality are reviewed from observational studies (The Collaborative Group on Hormonal Factors in Breast Cancer and The Million Women Study, 2019) and the Women's Health Initiative's (2020) two randomized trials evaluating conjugated equine estrogen alone, for women with prior hysterectomy or with medroxyprogesterone acetate. Findings are generally concordant for estrogen plus progestin use with both observational and randomized studies report...
Source: Cancer Journal - May 20, 2022 Category: Cancer & Oncology Authors: Rowan T Chlebowski JoAnn E Manson Source Type: research
